Skip to content
Screener

Delcath Systems DCTH Shares (Diluted)

Shares (Diluted) at other companies

Merit Medical Systems logo
Merit Medical SystemsMMSI
60M-2.1%
Boston Scientific logo
Boston ScientificBSX
1.5B-1.3%
Altimmune logo
AltimmuneALT
124.5M+64.7%
TriSalus Life Sciences, Inc. logo
TriSalus Life Sciences, Inc.TLSI
52.3M+83.4%
Wave Life Sciences logo
Wave Life SciencesWVE
204M+24.4%
CTO
Citius Oncology, Inc.CTOR
100M+39.8%

Other financials

Income statement

See full
Revenue$29.1M+20.6%
Gross profit$26.1M+25.5%
Operating income$2.4M-7.5%
Net income$2.7M-1.1%
EPS (diluted)$0.070.0%

Balance sheet

See full
Cash & equivalents$47.5M+38.0%
Total debt$2.5M+148%
Total equity$121.1M+15.4%
Total assets$137.0M+17.2%

Cash flow

See full
Operating cash flow$5.7M-21.7%
CapEx$503.0K+26.4%
Free cash flow$5.2M-24.5%

Valuation

See full
Market cap$578.43M+57.3%
Enterprise value$533.39M+59.6%
P/E112.9×
P/S6.1×+0.8×

Profitability

See full
Gross margin87.1%+1.2pp
Operating margin-118.1%-56.8pp
Net margin1.5%+0.8pp
FCF margin18.3%+12.8pp

Returns & leverage

See full
Return on equity1.9%+1.0pp
Debt / equity0.0×
Current ratio9.8×-1.0×

Where this comes from

Reported directly by Delcath Systems in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The source filing: Delcath Systems’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 9:09 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053956
Line itemThree months ended June 30, 2026Three months ended June 30, 2025Six months ended June 30, 2026Six months ended June 30, 2025
Unrealized gain on investments adjustments(295)57(250)296
Foreign currency translation adjustments(18)154(67)214
Total comprehensive income$2,355$2,908$1,281$4,276
Common share data:
Basic income per common share$0.07$0.08$0.04$0.11
Weighted average number of basic shares outstanding35,891,91535,786,81335,956,20535,217,887
Diluted income per common share$0.07$0.07$0.04$0.09
Weighted average number of dilutive shares outstanding39,761,48040,262,76439,584,32939,890,102

Item 1. Financial Statements

FAQ

What is Delcath Systems's shares (diluted)?
Delcath Systems (DCTH) reported shares (diluted) of 39.8M in Q2 2026.
How has Delcath Systems's shares (diluted) changed year-over-year?
Delcath Systems's shares (diluted) decreased by 1.2% year-over-year, from 40.3M to 39.8M.
What is the long-term trend for Delcath Systems's shares (diluted)?
Over 4 years (2021 to 2025), Delcath Systems's shares (diluted) has grown at a 54.7% compound annual growth rate (CAGR), from 27.9M to 159.8M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Ask your AI about Delcath Systems's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude